Answers are grounded in this paper and cite their sources.
Multiomics analysis reveals distinct subtypes of PDAC, implying potential for tailored treatments.
This integrative multiomics analysis delineates three biologically and clinically distinct PDAC subtypes. The results highlight metabolic and functional diversity underlying tumor heterogeneity, offering new insights for precision stratification and the development of targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: